Athira Pharma, Inc.

NASDAQ:ATHA

0.3278 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -96.94-117.672-95.639-54.853-19.955-5.161-5.097
Depreciation & Amortization 0.4550.9690.8450.4790.25100
Deferred Income Tax 0000-0.251-00
Stock Based Compensation 11.04910.62310.6064.6230.6330.2530.196
Change In Working Capital -11.9826.52711.9386.16-6.4450.6780.245
Accounts Receivables 001.109-1.036-0.001-00
Inventory 00-1.1091.0360.00100
Accounts Payables -5.7517.3672.1015.152.6010.7010.291
Other Working Capital -6.231-0.849.8371.01-9.046-0.0230.245
Other Non Cash Items 0.248-1.2-0.2190.4931.6540.5170.173
Operating Cash Flow -97.17-100.753-72.469-43.098-24.113-3.713-4.483
Investing Activities:
Investments In Property Plant And Equipment -0.033-0.304-1.141-1.573-2.3200
Acquisitions Net 00-0.0590.003000
Purchases Of Investments -14.134-27.671-95.288-299.197-226.837-0.995-5.25
Sales Maturities Of Investments 68.997123.064154.093296.69119.0532.4957.25
Other Investing Activites 000.059-0.0030.0360.0060.007
Investing Cash Flow 54.8395.08957.664-4.079-210.0681.5062.007
Financing Activities:
Debt Repayment 00001.6640.8741.266
Common Stock Issued 00.4930.65496.762208.5170.0720.112
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.1940.4930.6540.32782.5690.0720.198
Financing Cash Flow 0.1940.4930.65497.089292.750.9461.464
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -42.146-5.171-14.15149.91258.569-1.261-1.012
Cash At End Of Period 49.06991.21596.386110.53760.6252.0563.317